The original article can be found here.
Article highlights:
- Pharmacy group Clicks has upped its full-year dividend by 30%, saying this reflects the resilience of its model and the defensiveness of its core product offerings.
- The firm got a boost from a recovery in demand for beauty products, while it has also administered 3.5 million vaccines, which has helped lift retail sales.
- But the firm warns that it is feeling the pinch of load shedding and pressure on consumer spending.
